Last reviewed · How we verify

Coristina d — Competitive Intelligence Brief

Coristina d (Coristina d) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antihistamine/Decongestant combination. Area: Allergy/Cold and Flu.

phase 3 Antihistamine/Decongestant combination H1 histamine receptor; alpha-1 adrenergic receptor Allergy/Cold and Flu Small molecule Live · refreshed every 30 min

Target snapshot

Coristina d (Coristina d) — Brainfarma Industria Química e Farmacêutica S/A. Coristina D is a combination antihistamine and decongestant that reduces allergy and cold symptoms by blocking histamine receptors and constricting nasal blood vessels.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Coristina d TARGET Coristina d Brainfarma Industria Química e Farmacêutica S/A phase 3 Antihistamine/Decongestant combination H1 histamine receptor; alpha-1 adrenergic receptor
FEX60/PE10 FEX60/PE10 Sanofi phase 3 Antihistamine/decongestant combination H1 receptor (fexofenadine); alpha-1 adrenergic receptor (pseudoephedrine)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antihistamine/Decongestant combination class)

  1. Brainfarma Industria Química e Farmacêutica S/A · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Coristina d — Competitive Intelligence Brief. https://druglandscape.com/ci/coristina-d. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: